ATreg

N/A

Report date: 2023/12/11 18:14:02

Base Information

Drug NameATreg
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesActiTrexx GmbH
China Registration ClassN/A

Develop Information

Active CompaniesActiTrexx GmbH
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A